PT  - JOURNAL ARTICLE
AU  - Seo, Kyung-Ah
AU  - Kim, Hyo-Ji
AU  - Jeong, Eun Sook
AU  - Abdalla, Nagi
AU  - Choi, Chang-Soo
AU  - Kim, Dong-Hyun
AU  - Shin, Jae-Gook
TI  - In Vitro Assay of Six UDP-Glucuronosyltransferase Isoforms in Human Liver Microsomes, Using Cocktails of Probe Substrates and Liquid Chromatography–Tandem Mass Spectrometry
AID  - 10.1124/dmd.114.058818
DP  - 2014 Nov 01
TA  - Drug Metabolism and Disposition
PG  - 1803--1810
VI  - 42
IP  - 11
4099  - http://dmd.aspetjournals.org/content/42/11/1803.short
4100  - http://dmd.aspetjournals.org/content/42/11/1803.full
SO  - Drug Metab Dispos2014 Nov 01; 42
AB  - UDP-glucuronosyltransferase (UGT)–mediated drug–drug interactions are commonly evaluated during drug development. We present a validated method for the simultaneous evaluation of drug-mediated inhibition of six major UGT isoforms, developed in human liver microsomes through the use of pooled specific UGT probe substrates (cocktail assay) and rapid liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis. The six probe substrates used in this assay were estradiol (UGT1A1), chenodeoxycholic acid (UGT1A3), trifluoperazine (UGT1A4), 4-hydroxyindole (UGT1A6), propofol (UGT1A9), and naloxone (UGT2B7). In a cocktail incubation, UGT1A1, UGT1A9, and UGT2B7 activities were substantially inhibited by other substrates. This interference could be eliminated by dividing substrates into two incubations: one containing estradiol, trifluoperazine, and 4-hydroxyindole, and the other containing chenodeoxycholic acid, propofol, and naloxone. Incubation mixtures were pooled for the simultaneous analysis of glucuronyl conjugates in a single LC-MS/MS run. The optimized cocktail method was further validated against single-probe substrate assays using compounds known to inhibit UGTs. The degree of inhibition of UGT isoform activities by such known inhibitors in this cocktail assay was not substantially different from that in single-probe assays. This six-isoform cocktail assay may be very useful in assessing the UGT-based drug-interaction potential of candidates in a drug-discovery setting.